Clinical Trials Directory

Trials / Completed

CompletedNCT06616220

Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Effect of perineurial dexamethasone on erector spinal plane block duration for pediatric, idiopathic scoliosis surgery.

Detailed description

This study proposes to explore the effect of perineurial Dexamethasone on erector spinal plane block duration for pediatric idiopathic scoliosis surgery. Children need good analgesia after scoliosis surgery. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe. The safety of local anesthesia is essential in children due to the much lower toxicity threshold of local anesthetics. An effective adjuvant, such as Dexamethasone, could allow for a higher dilution of local anesthetics while maintaining and enhancing their analgesic effect.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneadministration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the erector spine plane block
DRUG0.9%NaCl0.9% NaCl

Timeline

Start date
2024-10-01
Primary completion
2025-10-07
Completion
2025-10-07
First posted
2024-09-27
Last updated
2025-11-24

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06616220. Inclusion in this directory is not an endorsement.